SCHEMBL58409

SCHEMBL58409

N[C@@H](CS)C(=O)S

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16033448 1.00 — —
SCHEMBL18095586 1.00 — —
SCHEMBL11585608 0.97 — —
SCHEMBL3165379 0.82 PTGS1 (0.43) —
Cystine SCHEMBL15667872 0.80 PTGS1 (0.58) —
SCHEMBL8430872 0.77 — —
SCHEMBL23897439 0.75 — —
Cysteine SCHEMBL5705426 0.75 PTGS1 (1.00) —
SCHEMBL358881 0.75 — —
SCHEMBL692227 0.75 — —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Appears in 9098 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20260146088-A1 ANTI-CD79B ANTIBODIES AND IMMUNOCONJUGATES AND METHODS OF USE GENENTECH, INC. (US) 2026-05-28 — — US claimed
US-20260137630-A1 COMPOSITIONS AND METHODS FOR T CELL TARGETED DELIVERY OF THERAPEUTIC AGENTS AND ACTIVATION OF T CELLS THE TRUSTEES OF THE UNIV OF PENNSYLVANIA (US) 2026-05-21 — — US claimed
US-20260137794-A1 LIGAND-DRUG CONJUGATE AND USE THEREOF SYSTIMMUNE INC (US) 2026-05-21 — — US claimed
CN-122011005-A Use of tris (trimethylsilyl) silane in disulfide hydrosilation reactions 中山大学 2026-05-12 — — CN claimed
WO-2026090156-A1 1,3,5-TRIAZINANE-2,4,6-TRIONE-DERIVED IONIZABLE LIPID COMPOUNDS AND LIPID NANOPARTICLES (LNPS) COMPRISING THE SAME THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA (US) 2026-04-30 — — WO claimed
EP-4637833-A2 CEREBLON DEGRADER CONJUGATES, AND USES THEREOF Genentech, Inc. (US) 2025-10-29 — — EP claimed
US-12440706-B2 Conjugated chemical inducers of degradation and methods of use GENENTECH, INC. (US) 2025-10-14 — — US claimed
WO-2025134068-A1 ANTIBODY DRUG CONJUGATES TARGETING PROTEINOPATHIES, AND USES THEREOF AC IMMUNE SA (CH) 2025-06-26 — — WO claimed
US-12296018-B2 Albumin binding peptide-drug (AlBiPeD) conjugates and methods of making and using same DUKE UNIVERSITY (US) 2025-05-13 — — US claimed
US-20250145575-A1 MACROMOLECULE-SUPPORTED 8-SULFONYL-BENZAZEPINE COMPOUNDS AND THEIR USES BOLT BIOTHERAPEUTICS, INC. (US) 2025-05-08 — — US claimed
WO-1993006217-A1 EXPRESSION IN E. COLI OF ANTIBODY FRAGMENTS HAVING AT LEAST A CYSTEINE PRESENT AS A FREE THIOL, USE FOR THE PRODUCTION OF BIFUNCTIONAL F(ab')2 ANTIBODIES GENENTECH, INC. (US) 1993-04-01 — — WO claimed
US-5132402-A Immobilized peptide which binds to human antibody to nicotinic acetylcholine receptor AGENCY OF INDUSTRIAL SCIENCE AND TECHNOLOGY (JP) 1992-07-21 — — US claimed
EP-0474789-A4 CYSTEINE THIOL-PROTECTED PEPTIDES FOR USE IN IMMUNOASSAYS — 1992-06-03 — — EP claimed
EP-0474789-A1 CYSTEINE THIOL-PROTECTED PEPTIDES FOR USE IN IMMUNOASSAYS GENETIC SYSTEMS CORPORATION (US) 1992-03-18 — — EP claimed
EP-0233973-B1 MIXTURE OF AMINO ACID DERIVATIVES, PROCESS OF PRODUCING THE MIXTURE AND USE OF THE MIXTURE FOR QUANTITATIVE DETERMINATION OF THE AMINO ACIDS Hewlett-Packard GmbH (DE) 1990-12-27 — — EP claimed
WO-1990015071-A1 CYSTEINE THIOL-PROTECTED PEPTIDES FOR USE IN IMMUNOASSAYS GENETIC SYSTEMS CORPORATION (US) 1990-12-13 — — WO claimed
US-4889917-A TREATMENT OF MYASTHENIA GRAVIS AGENCY OF INDUSTRIAL SCIENCE TECHNOLOGY, MINISTRY OF INTERNATIONAL TRADE & INDUSTRY (JP) 1989-12-26 — — US claimed
EP-0318240-A2 Peptide, adsorbent, method for production thereof, and method for use thereof AGENCY OF INDUSTRIAL SCIENCE &amp; TECHNOLOGY MINISTRY OF INTERNATIONAL TRADE &amp; INDUSTRY (JP) 1989-05-31 — — EP claimed
EP-0233973-A1 Mixture of amino acid derivatives, process of producing the mixture and use of the mixture for quantitative determination of the amino acids Hewlett-Packard GmbH (DE) 1987-09-02 — — EP claimed
EP-0105525-B1 THIOHYDRAZINE-1,2-DICARBONIC ACIDS, PROCESS FOR THEIR PREPARATION AND THEIR USE Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. (DE) 1986-09-10 — — EP claimed
Send feedback